PubRank

M Ramos-Casals

Author PubWeight™ 48.23‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Catastrophic antiphospholipid syndrome: clinical description and triggering factors in 8 patients. J Rheumatol 2000 2.06
2 Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review. Ann Rheum Dis 2010 2.05
3 Catastrophic antiphospholipid syndrome: clues to the pathogenesis from a series of 80 patients. Medicine (Baltimore) 2001 2.02
4 Previous antimalarial therapy in patients diagnosed with lupus nephritis: influence on outcomes and survival. Lupus 2008 2.00
5 Dementia associated with the antiphospholipid syndrome: clinical and radiological characteristics of 30 patients. Rheumatology (Oxford) 2004 1.68
6 Systemic lupus erythematosus (SLE) in childhood: analysis of clinical and immunological findings in 34 patients and comparison with SLE characteristics in adults. Ann Rheum Dis 1998 1.55
7 [Primary Sjögren's syndrome and lymphatic proliferation]. Med Clin (Barc) 2000 1.47
8 Validation of the preliminary criteria for the classification of catastrophic antiphospholipid syndrome. Ann Rheum Dis 2005 1.44
9 [Clinical manifestations and immunology associated with chronic infection with hepatitis C virus]. Rev Clin Esp 2002 1.39
10 Prospective analysis of neuropsychiatric events in an international disease inception cohort of patients with systemic lupus erythematosus. Ann Rheum Dis 2009 1.27
11 Anti-chromatin antibodies in systemic lupus erythematosus: a useful marker for lupus nephropathy. Ann Rheum Dis 2003 1.22
12 Cryoglobulinemia: study of etiologic factors and clinical and immunologic features in 443 patients from a single center. Medicine (Baltimore) 2001 1.17
13 Antiphospholipid syndrome associated with infections: clinical and microbiological characteristics of 100 patients. Ann Rheum Dis 2004 1.07
14 Cardiovascular risk factors and the long-term outcome of lupus nephritis. QJM 2001 1.06
15 Infections in systemic lupus erythematosus: a prospective and controlled study of 110 patients. Lupus 2006 1.05
16 Predicting adverse outcomes in primary Sjogren's syndrome: identification of prognostic factors. Rheumatology (Oxford) 2007 1.03
17 Association of antiphospholipid antibodies with retinal vascular disease in systemic lupus erythematosus. Semin Arthritis Rheum 1999 1.00
18 Systemic lupus erythematosus in Europe at the change of the millennium: lessons from the "Euro-Lupus Project". Autoimmun Rev 2005 0.97
19 Cardiovascular risk factors in primary Sjögren's syndrome: a case-control study in 624 patients. Lupus 2010 0.95
20 Circulating levels of Th1/Th2 cytokines in patients with primary Sjögren's syndrome: correlation with clinical and immunological features. Clin Exp Rheumatol 2001 0.93
21 The role of interleukin-10 promoter polymorphisms in the clinical expression of primary Sjögren's syndrome. Rheumatology (Oxford) 2002 0.92
22 The acute respiratory distress syndrome in catastrophic antiphospholipid syndrome: analysis of a series of 47 patients. Ann Rheum Dis 2005 0.92
23 [Evolution of Sjögren syndrome associated with hepatitis C virus when chronic hepatitis C is treated by interferon or the association of interferon and ribavirin]. Rev Med Interne 2005 0.89
24 Psychiatric and psychosocial disorders in patients with systemic lupus erythematosus: a longitudinal study of active and inactive stages of the disease. Lupus 2000 0.87
25 Autoantibodies as biomarkers for the prediction of neuropsychiatric events in systemic lupus erythematosus. Ann Rheum Dis 2011 0.87
26 Association of mannose-binding lectin gene polymorphisms with antiphospholipid syndrome, cardiovascular disease and chronic damage in patients with systemic lupus erythematosus. Rheumatology (Oxford) 2006 0.86
27 Antineutrophil cytoplasmic antibodies in primary Sjögren's syndrome: prevalence and clinical significance. Br J Rheumatol 1998 0.85
28 Successful treatment of severe Raynaud's phenomenon with bosentan in four patients with systemic sclerosis. Rheumatology (Oxford) 2004 0.85
29 Cryoglobulinemia in systemic lupus erythematosus: prevalence and clinical characteristics in a series of 122 patients. Semin Arthritis Rheum 2001 0.84
30 Disseminated intravascular coagulation in catastrophic antiphospholipid syndrome: clinical and haematological characteristics of 23 patients. Ann Rheum Dis 2005 0.84
31 Annular erythema in primary Sjogren's syndrome: description of 43 non-Asian cases. Lupus 2013 0.84
32 Nodular regenerative hyperplasia of the liver and antiphospholipid antibodies: report of two cases and review of the literature. Lupus 1999 0.83
33 Comparative analysis of subacute cutaneous lupus erythematosus and chronic cutaneous lupus erythematosus: clinical and immunological study of 270 patients. Br J Dermatol 2009 0.83
34 Primary Sjögren's syndrome in men: clinical and immunological characteristics. Lupus 2000 0.82
35 Primary Sjögren's syndrome in the elderly: clinical and immunological characteristics. Lupus 1999 0.81
36 Cutaneous lupus erythematosus: clinical and immunological study of 308 patients stratified by gender. Clin Exp Dermatol 2010 0.81
37 Influence of clinical and immunological parameters on the health-related quality of life of patients with primary Sjögren's syndrome. Clin Exp Rheumatol 2005 0.81
38 Splenectomy for refractory Evans' syndrome associated with antiphospholipid antibodies: report of two cases. Ann Rheum Dis 2000 0.80
39 White matter abnormalities in primary Sjögren syndrome. QJM 2011 0.80
40 SF-36 summary and subscale scores are reliable outcomes of neuropsychiatric events in systemic lupus erythematosus. Ann Rheum Dis 2011 0.80
41 Increased serum levels of soluble L-selectin (CD62L) in patients with active systemic lupus erythematosus (SLE). Clin Exp Immunol 2000 0.80
42 Registry of the Spanish Network for Systemic Sclerosis: Survival, Prognostic Factors, and Causes of Death. Medicine (Baltimore) 2015 0.79
43 Low values of creatine kinase in systemic lupus erythematosus. Clinical significance in 300 patients. Clin Exp Rheumatol 2003 0.78
44 Usefulness of basal and pilocarpine-stimulated salivary flow in primary Sjögren's syndrome. Correlation with clinical, immunological and histological features. Rheumatology (Oxford) 2002 0.78
45 Bronchiectasis in primary Sjögren's syndrome: prevalence and clinical significance. Clin Exp Rheumatol 2010 0.78
46 Coeliac disease associated with systemic sclerosis. Ann Rheum Dis 2004 0.78
47 Circulating concentrations of soluble L-selectin (CD62L) in patients with primary Sjögren's syndrome. Ann Rheum Dis 2000 0.77
48 Hepatitis G virus infection in primary Sjögren's syndrome: analysis in a series of 100 patients. Ann Rheum Dis 1998 0.77
49 Interleukin-4 receptor alpha polymorphisms in primary Sjögren's syndrome. Clin Exp Rheumatol 2004 0.76
50 Optic neuropathy in a child with primary Sjögren's syndrome. Rev Rhum Engl Ed 1998 0.76
51 Is hepatitis C virus a sialotropic virus? Am J Pathol 2001 0.76
52 Lessons from the "Euro-Lupus Cohort". Ann Med Interne (Paris) 2002 0.75
53 [Lupus nephropathy: implications of a long course]. Rev Clin Esp 2001 0.75
54 [Association of Sjögren syndrome, autoimmune thyroiditis, sarcoidosis, primary biliary cirrhosis and primary amyloidosis in a single patient]. Rev Clin Esp 2007 0.75
55 Catastrophic antiphospholipid syndrome presenting with renal thrombotic microangiopathy and diffuse proliferative glomerulonephritis. Clin Exp Rheumatol 2006 0.75
56 [Mixed cryoglobulinemia. Essential?]. Med Clin (Barc) 1999 0.75
57 [Sacroiliitis and Behçet disease]. An Med Interna 2006 0.75
58 [Primary antiphospholipid syndrome evolving into systemic lupus erythematosus: a report of 3 new cases and a review of the literature]. Rev Clin Esp 1999 0.75
59 Antiphospholipid syndrome and minimal change nephropathy. Lupus 2006 0.75
60 [Biologic therapies for systemic autoimmune diseases. Are expectations met?]. Farm Hosp 2009 0.75